U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07846059) titled 'Evaluation of Mavacamten-Based Practice in Chinese Adults With Obstructive Hypertrophic Cardiomyopathy' on Sept. 23.
Brief Summary: The study will describe how mavacamten is used in routine care for Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), including use as monotherapy or with other background/concomitant oHCM medications.
Study Start Date: Sept. 30
Study Type: OBSERVATIONAL
Condition:
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Intervention:
DRUG: Mavacamten
As per product label
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Published by HT Digital Content Se...